Browsing "1. Journal Papers" by Author : 4229

All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:
  • Sort by:
  • In order:
  • Results/Page
  • Authors/Record:

Showing results 1 to 14 of 14

This table browses all dspace content
Issue DateTitleJournal Title
2018A Prediction Model of Tumor Progression and Survival in HER2-Positive Metastatic Gastric Cancer Patients Treated with Trastuzumab and ChemotherapyAAPS JOURNAL
2022A single arm phase Ib/II trial of first-line pembrolizumab, trastuzumab and chemotherapy for advanced HER2-positive gastric cancer NATURE COMMUNICATIONS
2011Advanced detection of recent changing trends in gastric cancer survival: up-to-date comparison by period analysis. JAPANESE JOURNAL OF CLINICAL ONCOLOGY
2013Application of the Adjuvant! Online Model to Korean Breast Cancer Patients: An Assessment of Prognostic Accuracy and Development of an Alternative Prognostic ToolANNALS OF SURGICAL ONCOLOGY
2021Comparative efficacy and tolerability of third-line treatments for advanced gastric cancer: A systematic review with Bayesian network meta-analysisEUROPEAN JOURNAL OF CANCER
2021Detection of asymptomatic recurrence improves survival of gastric cancer patients CANCER MEDICINE
2019Mesothelin Expression Is a Predictive Factor for Peritoneal Recurrence in Curatively Resected Stage III Gastric CancerONCOLOGIST
2024Open-Label, Multicenter, Randomized, Biomarker-Integrated Umbrella Trial for Second-Line Treatment of Advanced Gastric Cancer: K-Umbrella Gastric Cancer StudyJOURNAL OF CLINICAL ONCOLOGY
2014Phase II gemcitabine and capecitabine combination therapy in recurrent or metastatic breast cancer patients pretreated with anthracycline and taxaneCANCER CHEMOTHERAPY AND PHARMACOLOGY
2013Prognostic Value of Mucinous Histology Depends on Microsatellite Instability Status in Patients with Stage III Colon Cancer Treated with Adjuvant FOLFOX Chemotherapy: A Retrospective Cohort StudyANNALS OF SURGICAL ONCOLOGY
2019Randomised phase II trial comparing four front-line doublets in Asian patients with metastatic gastric cancerEUROPEAN JOURNAL OF CANCER
2024Second-line chemoimmunotherapy with nivolumab and paclitaxel in immune-related biomarker-enriched advanced gastric cancer: a multicenter phase Ib/II studyGASTRIC CANCER
2019Temsirolimus in Asian Metastatic/Recurrent Non-clear Cell Renal Carcinoma CANCER RESEARCH AND TREATMENT
2023Trastuzumab Combined With Ramucirumab and Paclitaxel in Patients With Previously Treated Human Epidermal Growth Factor Receptor 2–Positive Advanced Gastric or Gastroesophageal Junction CancerJOURNAL OF CLINICAL ONCOLOGY
1

Browse

Links